Bank of Montreal Can lowered its position in Genpact Limited (NYSE:G – Free Report) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 314,943 shares of the business services provider’s stock after selling 7,455 shares during the period. Bank of Montreal Can owned 0.18% of Genpact worth $12,204,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in G. CWM LLC lifted its holdings in shares of Genpact by 160.8% during the second quarter. CWM LLC now owns 952 shares of the business services provider’s stock valued at $31,000 after purchasing an additional 587 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its position in Genpact by 54.3% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 2,797 shares of the business services provider’s stock valued at $90,000 after buying an additional 984 shares in the last quarter. Venturi Wealth Management LLC raised its stake in Genpact by 74.6% during the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock valued at $103,000 after buying an additional 1,121 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Genpact by 221.3% in the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock worth $131,000 after acquiring an additional 2,293 shares in the last quarter. Finally, Centaurus Financial Inc. purchased a new stake in shares of Genpact in the third quarter worth $159,000. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. Needham & Company LLC increased their price target on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. JPMorgan Chase & Co. increased their target price on Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. BMO Capital Markets boosted their price target on Genpact from $38.00 to $42.00 and gave the stock a “market perform” rating in a research note on Monday, August 12th. TD Cowen upped their price target on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a report on Friday, November 8th. Finally, Robert W. Baird lifted their price objective on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $42.33.
Genpact Price Performance
Shares of NYSE:G opened at $46.16 on Monday. The company has a market capitalization of $8.14 billion, a P/E ratio of 12.68, a P/E/G ratio of 1.59 and a beta of 1.13. Genpact Limited has a 1-year low of $30.23 and a 1-year high of $47.98. The firm’s 50 day simple moving average is $41.17 and its two-hundred day simple moving average is $37.02. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85.
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be given a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Monday, December 9th. Genpact’s dividend payout ratio is currently 16.76%.
Insider Activity at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares of the company’s stock, valued at $12,407,545.60. This represents a 3.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.80% of the stock is owned by corporate insiders.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
- Five stocks we like better than Genpact
- Canada Bond Market Holiday: How to Invest and Trade
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is a Dividend King?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What is a Special Dividend?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.